Randomized COVID-19 Vaccination Rollout

5 Pages Posted: 1 Apr 2021

See all articles by Lars G. Hemkens

Lars G. Hemkens

University of Basel - University Hospital Basel

Steven Goodman

Stanford University - School of Medicine

Date Written: March 5, 2021


Vaccines will be vital to control the Coronavirus disease 2019 (COVID-19) pandemic, but the pressure to quickly move from research to implementation raises concerns about benefits and harms, vaccine acceptance and fair access. Here we present a strategy for the COVID-19 vaccination rollout which can be rapidly embedded and would offer direct real-world evidence of vaccines on a large scale to generate otherwise unobtainable knowledge on the safety and perhaps efficacy of COVID-19 vaccines.

Note: Funding Statement: None.

Declaration of Interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf. There are no relationships or activities that could appear to have influenced the submitted work.

Keywords: COVID-19, vaccines, randomization, study design

Suggested Citation

Hemkens, Lars and Goodman, Steven, Randomized COVID-19 Vaccination Rollout (March 5, 2021). Available at SSRN: https://ssrn.com/abstract=3798630 or http://dx.doi.org/10.2139/ssrn.3798630

Lars Hemkens (Contact Author)

University of Basel - University Hospital Basel ( email )

Wilhelm-Klein-Strasse 27
Basel, 4025

Steven Goodman

Stanford University - School of Medicine ( email )

291 Campus Drive
Li Ka Shing Building
Stanford, CA 94305-5101
United States

Do you want regular updates from SSRN on Twitter?

Paper statistics

Abstract Views
PlumX Metrics